|Genomic hallmarks of localized, non-indolent prostate cancer|
M Fraser, VY Sabelnykova, TN Yamaguchi, LE Heisler, J Livingstone, ...
Nature 541 (7637), 359-364, 2017
|Mutant IDH1 downregulates ATM and alters DNA repair and sensitivity to DNA damage independent of TET2|
S Inoue, WY Li, A Tseng, I Beerman, AJ Elia, SC Bendall, F Lemonnier, ...
Cancer cell 30 (2), 337-348, 2016
|Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort|
D Trudel, MR Downes, J Sykes, KJ Kron, J Trachtenberg, ...
European Journal of Cancer 50 (9), 1610-1616, 2014
|TMPRSS2–ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer|
KJ Kron, A Murison, S Zhou, V Huang, TN Yamaguchi, YJ Shiah, M Fraser, ...
Nature genetics 49 (9), 1336, 2017
|Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression|
L Liu, KJ Kron, VV Pethe, N Demetrashvili, ME Nesbitt, J Trachtenberg, ...
International journal of cancer 129 (10), 2454-2462, 2011
|Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays|
K Kron, V Pethe, L Briollais, B Sadikovic, H Ozcelik, A Sunderji, ...
PloS one 4 (3), e4830, 2009
|Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation|
F Antignano, K Burrows, MR Hughes, JM Han, KJ Kron, NM Penrod, ...
The Journal of clinical investigation 124 (5), 1945-1955, 2014
|Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer|
SD Bailey, K Desai, KJ Kron, P Mazrooei, NA Sinnott-Armstrong, ...
Nature genetics 48 (10), 1260, 2016
|DNA methylation of HOXD3 as a marker of prostate cancer progression|
KJ Kron, L Liu, VV Pethe, N Demetrashvili, ME Nesbitt, J Trachtenberg, ...
Laboratory investigation 90 (7), 1060-1067, 2010
|The proteogenomic landscape of curable prostate cancer|
A Sinha, V Huang, J Livingstone, J Wang, NS Fox, N Kurganovs, ...
Cancer Cell 35 (3), 414-427. e6, 2019
|Correlation of ERG expression and DNA methylation biomarkers with adverse clinicopathologic features of prostate cancer|
K Kron, L Liu, D Trudel, V Pethe, J Trachtenberg, N Fleshner, B Bapat, ...
Clinical cancer research 18 (10), 2896-2904, 2012
|Novel multiplex MethyLight protocol for detection of DNA methylation in patient tissues and bodily fluids|
E Olkhov-Mitsel, D Zdravic, K Kron, T van der Kwast, N Fleshner, B Bapat
Scientific reports 4 (1), 1-8, 2014
|Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer|
E Olkhov-Mitsel, T Van der Kwast, K Kron, H Ozcelik, L Briollais, ...
Epigenetics 7 (9), 1037-1045, 2012
|Enhancer alterations in cancer: a source for a cell identity crisis|
KJ Kron, SD Bailey, M Lupien
Genome medicine 6 (9), 1-12, 2014
|Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression|
P Saraon, D Trudel, K Kron, A Dmitromanolakis, J Trachtenberg, B Bapat, ...
The Prostate 74 (4), 372-380, 2014
|Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer|
C Poyet, L Buser, F Roudnicky, M Detmar, T Hermanns, D Mannhard, ...
Journal of clinical pathology 68 (10), 819-824, 2015
|Epigenome-wide DNA methylation profiling identifies differential methylation biomarkers in high-grade bladder cancer|
E Olkhov-Mitsel, AJ Savio, KJ Kron, VV Pethe, T Hermanns, NE Fleshner, ...
Translational oncology 10 (2), 168-177, 2017
|Dynamic interplay between locus-specific DNA methylation and hydroxymethylation regulates distinct biological pathways in prostate carcinogenesis|
SN Kamdar, LT Ho, KJ Kron, R Isserlin, T van der Kwast, AR Zlotta, ...
Clinical epigenetics 8 (1), 1-17, 2016
|Pre-neoplastic epigenetic disruption of transcriptional enhancers in chronic inflammation|
AC Planello, R Singhania, KJ Kron, SD Bailey, D Roulois, M Lupien, ...
Oncotarget 7 (13), 15772, 2016
|Altered DNA methylation landscapes of polycomb-repressed loci are associated with prostate cancer progression and ERG oncogene expression in prostate cancer|
K Kron, D Trudel, V Pethe, L Briollais, N Fleshner, T van der Kwast, ...
Clinical cancer research 19 (13), 3450-3461, 2013